CG Oncology, Inc. (CGON) ROA
- 2026-06-30: ROA -20.67%.
- 2026-03-31: ROA -16.45%.
- 2025-12-31: ROA -20.34%.
- 2025-09-30: ROA -20.75%.
Complete source-backed roa history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -20.67% |
| 2026-03-31 | -16.45% |
| 2025-12-31 | -20.34% |
| 2025-09-30 | -20.75% |
| 2025-06-30 | -18.26% |
| 2025-03-31 | -14.50% |
| 2024-12-31 | -11.66% |
| 2024-09-30 | -13.18% |
| 2024-06-30 | -11.37% |
| 2024-03-31 | -9.82% |
| 2023-12-31 | -24.39% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -20.34% |
| 2024-12-31 | -11.66% |
| 2023-12-31 | -24.39% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |